Galectin Therapeutics Inc Cash Flow-to-Debt Ratio
Galectin Therapeutics Inc cash flow-to-debt ratio. Galectin Therapeutics Inc (GALT) has a Cash Flow-to-Debt Ratio of -0.03x as of March 2026, meaning its operating cash flow of $-3.87 Million could theoretically repay 0% of its total liabilities ($146.00 Million) in one year. Check Galectin Therapeutics Inc (GALT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Galectin Therapeutics Inc (2000–2025)
Cash flow-to-debt ratio of Galectin Therapeutics Inc from 2000 to 2025. Historical debt coverage capacity for Galectin Therapeutics Inc across 26 annual periods. Also explore GALT net asset momentum to track the company's year-over-year net asset growth rate.
Galectin Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2000–2025)
Galectin Therapeutics Inc cash flow-to-debt ratio by year from 2000 to 2025. Year-by-year debt coverage analysis for Galectin Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Galectin Therapeutics Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | $-23.88 Million | $145.73 Million | ▲ +52.7% |
| 2024 | -0.35x | $-41.77 Million | $120.56 Million | ▲ +7.1% |
| 2023 | -0.37x | $-32.97 Million | $88.44 Million | ▲ +35.8% |
| 2022 | -0.58x | $-31.06 Million | $53.48 Million | ▲ +6.3% |
| 2021 | -0.62x | $-24.31 Million | $39.21 Million | ▲ +83.7% |
| 2020 | -3.81x | $-20.60 Million | $5.41 Million | ▼ -0.9% |
| 2019 | -3.78x | $-10.85 Million | $2.87 Million | ▲ +21.8% |
| 2018 | -4.83x | $-10.18 Million | $2.11 Million | ▲ +9.8% |
| 2017 | -5.35x | $-15.89 Million | $2.97 Million | ▼ -23.3% |
| 2016 | -4.34x | $-16.41 Million | $3.78 Million | ▲ +65.2% |
| 2015 | -12.49x | $-16.98 Million | $1.36 Million | ▼ -71.1% |
| 2014 | -7.30x | $-12.43 Million | $1.70 Million | ▼ -142.4% |
| 2013 | -3.01x | $-7.48 Million | $2.49 Million | ▲ +34.0% |
| 2012 | -4.56x | $-7.50 Million | $1.64 Million | ▼ -78.0% |
| 2011 | -2.56x | $-5.68 Million | $2.21 Million | ▼ -560.4% |
| 2010 | -0.39x | $-3.10 Million | $7.99 Million | ▲ +51.1% |
| 2009 | -0.79x | $-3.89 Million | $4.90 Million | ▲ +80.1% |
| 2008 | -3.98x | $-4.67 Million | $1.17 Million | ▼ -241.3% |
| 2007 | -1.17x | $-5.48 Million | $4.71 Million | ▼ -10.1% |
| 2006 | -1.06x | $-6.76 Million | $6.38 Million | ▲ +76.2% |
| 2005 | -4.44x | $-6.13 Million | $1.38 Million | ▲ +29.5% |
| 2004 | -6.30x | $-6.33 Million | $1.00 Million | ▲ +42.6% |
| 2003 | -10.99x | $-4.15 Million | $377.91K | ▼ -145.6% |
| 2002 | -4.47x | $-2.98 Million | $666.79K | ▼ -36.9% |
| 2001 | -3.27x | $-1.80 Million | $550.70K | ▼ -553.5% |
| 2000 | -0.50x | $-90.00K | $180.00K | — |